These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7705964)

  • 1. Toxicity of high doses of polyclonal drug-specific antibody Fab fragments.
    Keyler DE; Shelver WL; Landon J; Sidki A; Pentel PR
    Int J Immunopharmacol; 1994 Dec; 16(12):1027-34. PubMed ID: 7705964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of desipramine toxicity in rats with polyclonal drug-specific antibody Fab fragments.
    Pentel PR; Ross CA; Landon J; Sidki A; Shelver WL; Keyler DE
    J Lab Clin Med; 1994 Mar; 123(3):387-93. PubMed ID: 8133150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of desipramine cardiotoxicity and prolongation of survival in rats with the use of polyclonal drug-specific antibody Fab fragments.
    Pentel PR; Scarlett W; Ross CA; Landon J; Sidki A; Keyler DE
    Ann Emerg Med; 1995 Sep; 26(3):334-41. PubMed ID: 7661425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of desipramine toxicity in rats using drug-specific antibody Fab' fragment: effects on hypotension and interaction with sodium bicarbonate.
    Brunn GJ; Keyler DE; Pond SM; Pentel PR
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1392-9. PubMed ID: 1312169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-specific F(ab')2 fragment reduces desipramine cardiotoxicity in rats.
    Brunn GJ; Keyler DE; Ross CA; Pond SM; Pentel PR
    Int J Immunopharmacol; 1991; 13(7):841-51. PubMed ID: 1761350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of specific antibody Fab fragments on desipramine pharmacokinetics in the rat in vivo and in the isolated, perfused liver.
    Keyler DE; Le Couteur DG; Pond SM; St Peter JV; Pentel PR
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1117-23. PubMed ID: 7891324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovine desipramine antibody fragments reverse desipramine cardiovascular toxicity in the rat.
    Dart RC; Sidki A; Sullivan JB; Egen NB; Garcia RA
    Ann Emerg Med; 1996 Mar; 27(3):309-15. PubMed ID: 8599489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and mechanism of action of sodium bicarbonate in the treatment of desipramine toxicity in rats.
    Pentel P; Benowitz N
    J Pharmacol Exp Ther; 1984 Jul; 230(1):12-9. PubMed ID: 6086872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment with drug-specific antibody reduces desipramine cardiotoxicity in rats.
    Pentel PR; Brunn GJ; Pond SM; Keyler DE
    Life Sci; 1991; 48(7):675-83. PubMed ID: 1990238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of high dose alpha-1-acid glycoprotein on desipramine toxicity in rats.
    Pentel PR; Keyler DE
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1061-6. PubMed ID: 3418509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tricyclic antidepressant-specific Fab fragments alter the distribution and elimination of desipramine in the rabbit: a model for overdose treatment.
    Hursting MJ; Opheim KE; Raisys VA; Kenny MA; Metzger G
    J Toxicol Clin Toxicol; 1989; 27(1-2):53-66. PubMed ID: 2769821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of recombinant drug-specific single chain antibody Fv fragment on [3H]-desipramine distribution in rats.
    Shelver WL; Keyler DE; Lin G; Murtaugh MP; Flickinger MC; Ross CA; Pentel PR
    Biochem Pharmacol; 1996 Feb; 51(4):531-7. PubMed ID: 8619899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-specific antibodies as antidotes for tricyclic antidepressant overdose.
    Pentel PR; Keyler DE
    Toxicol Lett; 1995 Dec; 82-83():801-6. PubMed ID: 8597145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide contributes to desipramine-induced hypotension in rats.
    Pentel PR; Wananukul W; Scarlett W; Keyler DE
    Hum Exp Toxicol; 1996 Apr; 15(4):320-8. PubMed ID: 8845222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid administration of high-dose human antibody Fab fragments to dogs: pharmacokinetics and toxicity.
    Keyler DE; Salerno DM; Murakami MM; Ruth G; Pentel PR
    Fundam Appl Toxicol; 1991 Jul; 17(1):83-91. PubMed ID: 1916083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redistribution of tricyclic antidepressants in rats using a drug-specific monoclonal antibody: dose-response relationship.
    Pentel PR; Keyler DE; Brunn GJ; Milavetz JM; Gilbertson DG; Matta SG; Pond SM
    Drug Metab Dispos; 1991; 19(1):24-8. PubMed ID: 1673407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial expression and characterization of an anti-desipramine single-chain antibody fragment.
    Lin G; Pentel PR; Shelver WL; Keyler DE; Ross CA; Hieda Y; Flickinger MC; Pennell CA; Murtaugh MP
    Int J Immunopharmacol; 1996 Dec; 18(12):729-38. PubMed ID: 9172016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and toxicity of high doses of antibody Fab fragments in rats.
    Pentel PR; Keyler DE; Gilbertson DG; Ruth G; Pond SM
    Drug Metab Dispos; 1988; 16(1):141-5. PubMed ID: 2894943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of advanced digitoxin toxicity and modification of pharmacokinetics by specific antibodies and Fab fragments.
    Ochs HR; Smith TW
    J Clin Invest; 1977 Dec; 60(6):1303-13. PubMed ID: 914999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digoxin-specific antibody fragments in the treatment of digoxin toxicity.
    Chan BS; Buckley NA
    Clin Toxicol (Phila); 2014; 52(8):824-36. PubMed ID: 25089630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.